The suspected infectious agent was a parasite protozoan named Trypanosoma cruzi. This parasite is transmitted to humans mainly through the feces of infected Kissing bugs.

Chagas disease is classified as a zoonotic disease. A zoonotic disease is an infectious disease that can be transmitted between animals and humans. In the case of Chagas disease, wild animals serve as natural reservoirs of the T. cruzi parasite, and the infection spreads to humans through insect vectors.

In the mid-20th century the disease remained largely confined to Latin America, affecting millions in rural areas. Around the late 20th to early 21st century increased migration led to the detection of Chagas disease cases in non-endemic countries, including the United States and parts of Europe. The World Health Organization (WHO) has recognized Chagas disease as a global public health concern.

Globally approximately 6–7 million people worldwide are estimated to be infected with Trypanosoma cruzi. The disease leads to about 12,000 deaths annually. In the United States an estimated 288,000 individuals are infected including 57,000 with Chagas cardiomyopathy.

Chagas disease has a variable virulence that depends on the host's immune response and the genetic makeup of the particular strained of Chagas Disease. Acute infection symptoms can range from mild to severe, including fever, fatigue, and swelling at the site of infection. In the case of Chronic Chagas disease this can be much more severe, affecting organs like the heart and digestive system, leading to life-threatening complications if left untreated.

Chagas disease has shown some variations over time, especially as it spreads to different regions of the world. Host immunity, the genetic diversity of the Chagas diseease strains, and environmental changes can affect virulence levels. The spread of Chagas Disease has spread to urban settings and other continents due to migration, which has impacted the disease expression and transmission. Access to treatment and screening programs has likely helped reduce severe manifestations of Chagas over time, but more effective interventions are needed for chronic infections to further reduce virulence and disease impact.

Programs have been implemented that spray homes with insecticides, and housing improvements to keep out kissing bugs that spread the disease. Blood banks screened donations, and pregnant women are tested to prevent passing the disease to their babies. Lastly, at local clinics doctors and nurses are trained to spot symptoms early and provide medicines like benznidazole or nifurtimox.

Drugs like benznidazole and nifurtimox have become widely available, especially for treating early-stage infection, and testing and treating newborns helps to prevent serious problems later in life. Additionally, tests like the ELISA and PCR make it easier to find the disease early on.

Scientists have studied the genome of Trypanosoma cruzi to understand how it works and to find better treatments, and small, portable kits have been developed to test for the disease in remote areas. Insecticidal paints, bed nets, and even experiments with genetically modified bugs have been used to stop the spread.

Additionally, apps and mapping tools helped track outbreaks and target problem areas faster.

These combined efforts helped reduce infections and improved care in areas hit hardest by Chagas disease.

In many Latin American countries, insecticidal paints and home upgrades helped reduce bug habitats.

Non-endemic countries utilized portable diagnostic kits and advanced lab tests to quickly identify cases in immigrants and travelers. Globally, WHO, PAHO, and NGOs raised awareness, funded research, and supported access to treatment worldwide.

Conclusively, in reviewing the response to this endemic, many Latin American countries could bolster consistent funding and expand healthcare in rural areas, which would be beneficial for addressing chronic and undetected cases to flatten the curve. Meanwhile, non-endemic countries should focus on raising awareness among healthcare providers to detect and treat imported Chagas cases earlier and increase funding for vaccine research.

Society has changed its behaviors in response to managing the disease. Improvements in housing have reduced habitats for the insects that spread Chagas. Blood screening programs have been implemented to prevent transmission through transfusions, and public health campaigns have promoted prevention methods.

Additionally, Chagas disease management is now better integrated into primary healthcare. This includes training healthcare workers and making diagnostic tools and treatments more accessible.

Overall, Chagas disease highlighted weaknesses in healthcare systems and social structures. However, it also led to progress in public health strategies and increased global awareness of neglected diseases.

What did you learn about Chagas disease that surprised you?
I didn’t expect to see how much effort goes into managing the disease. Things like spraying homes with insecticides, improving houses to keep bugs out, and using portable test kits in remote areas were new to me. It was also surprising to learn that scientists are studying the parasite’s DNA and even using genetically modified bugs to try and stop the disease. The economic struggles caused by the disease for people and families were also saddening, but not unexpected.

What should have been added to the Padlet assignment?
The role of technology, like apps and maps to track outbreaks, should have been included. This shows how modern tools are helping fight the disease. I also think it would help to mention how groups like WHO and PAHO are working together globally to tackle Chagas. Finally, adding more about how the disease can lead to serious heart problems (Chagas cardiomyopathy) would have made my Padlet more complete.